GlassScriptPhysician profile
Harishchandra Mahaseth
NPI 1043476922
$1,256.72
in general payments reported to CMS, 2019-2025
17 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $211 · 2020: $17.96 · 2022: $560 · 2023: $295 · 2024: $173.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $468.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $467.88 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $360.74 | 2022-2024 | Rybelsus, Ozempic |
| Boehringer Ingelheim Pharmaceuticals, INC. | $297.26 | 2019-2024 | Jardiance |
| Astrazeneca Pharmaceuticals LP | $150.95 | 2019-2022 | |
| Glaxosmithkline, LLC. | $135.61 | 2022-2023 | Arexvy, Shingrix |
| Insulet Corporation | $76.32 | 2023 | Omnipod |
| Novartis Pharmaceuticals Corporation | $30.88 | 2019-2023 | |
| Kowa Pharmaceuticals America, INC. | $26.34 | 2022-2023 | Seglentis, Livalo |
| Harmony Biosciences LLC | $24.68 | 2023 | Wakix |
| Abbott Laboratories | $24.42 | 2023 | Proclaim |
| Baxter Healthcare | $21.87 | 2023 | Hillrom - Cardiac Ambulatory Monitor |
| Tetraphase Pharmaceuticals, INC. | $17.96 | 2020 | |
| Ani Pharmaceuticals, INC. | $16.84 | 2024 | Purified Cortrophin Gel |
| Pfizer INC. | $16.77 | 2023 | |
| Xeris Pharmaceuticals, INC. | $16.57 | 2023 | Gvoke Hypopen |
| Amgen INC. | $15.90 | 2024 | Repatha, Otezla |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $12.80 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $10.81 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Harishchandra Mahaseth listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.